FDA Drug Application (206276) for PAZEO by ALCON RES LTD

Back to FDA Applications sponsored by ALCON RES LTD

Application Number206276
Product Number001
FormSOLUTION/DROPS;OPHTHALMIC
DosageEQ 0.7% BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePAZEO
Active IngredientOLOPATADINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient OLOPATADINE HYDROCHLORIDE5


Back to FDA Applications sponsored by ALCON RES LTD